Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Positive Regulator Molecules

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

Cooperative Allosteric Transitions

Cooperative Allosteric Transitions

Cooperative Allosteric Transitions

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...

Allosteric Regulation

Allosteric Regulation

Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

AOP Network Box: An Integrative Framework for Bridging Adverse Outcome Pathways and Biological Networks.

Chemical research in toxicology·2026

Same author

scMix: learning temporal dynamics of gene expression under irregular time intervals.

Bioinformatics (Oxford, England)·2026

Same author

Trends in Widefield Fundus Photography and Optical Coherence Tomography Examination in South Korea (2015-2024).

Korean journal of ophthalmology : KJO·2025

Same author

Cancer-Associated Retinopathy in a Patient with Small Cell Lung Cancer and Esophageal Cancer: A Case Report.

Korean journal of ophthalmology : KJO·2025

Same author

BIDpred: unraveling B cell Immunodominance hierarchical pattern using statistical feature discovery and deep learning prediction.

Frontiers in immunology·2025

Same author

Morphological characteristics of high myopes complicated by serous retinal detachment with dome-shaped macula or inferior staphyloma.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2025

Search research articles

Related Experiment Video

Updated: Nov 25, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Autonomous molecule generation using reinforcement learning and docking to develop potential novel inhibitors.

Woosung Jeon¹, Dongsup Kim²

¹Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.

Scientific Reports

|December 17, 2020

Summary

We created MORLD, a novel computational method using reinforcement learning and docking to automatically design potential drug compounds. This tool efficiently generates new inhibitors and agonists for target proteins like DDR1 and D4DR.

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Experiment Videos

Last Updated: Nov 25, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Area of Science:

Computational chemistry
Drug discovery
Artificial intelligence in medicine

Background:

Developing novel drug candidates is a time-consuming and resource-intensive process.
Traditional methods often rely on extensive screening of large compound libraries.

Purpose of the Study:

To develop an automated computational method for generating and optimizing potential drug compounds.
To demonstrate the efficacy of this method in identifying novel inhibitors and agonists for specific protein targets.

Main Methods:

Developed Molecule Optimization by Reinforcement Learning and Docking (MORLD), a hybrid computational approach.
Utilized reinforcement learning and molecular docking simulations.
Required only target protein structure and modified ligand structures.

Main Results:

Successfully generated potential novel inhibitors for discoidin domain receptor 1 kinase (DDR1) within two days.
Generated potential novel agonists for the D4 dopamine receptor (D4DR) from scratch.
Achieved higher predicted binding affinity without extensive training data or virtual screening.

Conclusions:

MORLD is an efficient and effective computational tool for de novo drug design.
The method accelerates the identification of potential therapeutic agents.
A free web server for MORLD is publicly accessible for research use.